Quick Takeaways
- GLAZER CAPITAL, LLC filed SCHEDULE 13G/A for Astria Therapeutics, Inc. Common Stock, $0.001 par value per share (ATXS).
- Disclosed ownership: 6.6%.
- Date of event: 31 Dec 2025.
GLAZER CAPITAL, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Astria Therapeutics, Inc. Common Stock, $0.001 par value per share (ATXS)
- Filing Manager
- GLAZER CAPITAL, LLC
- Reporting Manager
- Glazer Capital, LLC
- Symbol
- ATXS
- Shares outstanding
- 57,127,897 shares
- Disclosed Ownership
- 3,776,154 shares
- Ownership
- 6.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2026, 16:58:09 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 10 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GLAZER CAPITAL, LLC disclosed 6.6% ownership in Astria Therapeutics, Inc. Common Stock, $0.001 par value per share (ATXS) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 10 Dec 2025.
- Current filing was accepted on 12 Feb 2026, 16:58.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Glazer Capital, LLC | 6.6% | 3,776,154 | 0 | 3,776,154 | Paul J. Glazer | Paul J. Glazer, Managing Member | |
| Paul J. Glazer | 6.6% | 3,776,154 | 0 | 3,776,154 | Paul J. Glazer | Paul J. Glazer |